Comparison of Iodine + Isopropyl Alcohol Versus Iodine + Antimicrobial Sealant for Skin Preparation

NCT ID: NCT01110772

Last Updated: 2010-04-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

1200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-05-31

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose if this study is to determine whether a microbial sealant (iodine + cyanoacrylate) \[InteguSEAL®, Kimberly-Clark\] reduces surgical site infections when compared to iodine and isopropyl alcohol (povacrylex in isopropyl alcohol) \[Duraprep®\] in oncologic surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patient's skin flora is a major source of pathogens, and microbial contamination of the surgical site is a likely precursor of SSI. A variety of skin products may be used, including iodophors, alcohol-containing products, and clorhexidine gluconate. Despite these perioperative tactics, bacteria continue to survive at the skin level and migrate to contaminate the wound.

A microbial sealant (InteguSEAL®, Kimberly-Clark) that uses cyanoacrylate to seal endogenous skin flora has demonstrated to reduce wound contamination. The efficacy of the microbial sealant in preventing SSI has been tested in cardiovascular surgery and open inguinal hernia repair, with a reduction on SSI rate when compared to standard skin preparations. This cyanoacrylate has not been tested in oncologic surgeries.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surgical Site Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2-octyl cyanoacrylate

As recommended, povidone iodine is used for skin antisepsis. After drying, a layer of cyanoacrylate is applied on the skin surface with the purpose of immobilizing skin bacteria.

Group Type EXPERIMENTAL

2-octyl cyanoacrylate [InteguSEAL®]

Intervention Type DEVICE

At operating room arrival prior to surgery, povidone-iodine is applied on the skin surface on concentric circles as recommended; after drying, the cyanoacrylate device is opened and a layer of the sealant is applied on the incision and skin site(IS100 for patients undergoing mastectomy, and IS200 for patients undergoing gynecologic or digestive tract surgeries).

iodine povacrylex in isopropyl alcohol

Iodine povacrylex in isopropyl alcohol (Duraprep 3M) This is considered a standard of care in our hospital as many other institutions. It's efficacy and safety have been demonstrated.

Group Type ACTIVE_COMPARATOR

Iodine povacrylex in isopropyl alcohol [Duraprep®, 3M]

Intervention Type DEVICE

At the operating room arrival a few minutes before the incision, cleansing and skin antisepsis is done with the prefilled device with iodine povacrylex in isopropyl alcohol as recommended by 3M.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

2-octyl cyanoacrylate [InteguSEAL®]

At operating room arrival prior to surgery, povidone-iodine is applied on the skin surface on concentric circles as recommended; after drying, the cyanoacrylate device is opened and a layer of the sealant is applied on the incision and skin site(IS100 for patients undergoing mastectomy, and IS200 for patients undergoing gynecologic or digestive tract surgeries).

Intervention Type DEVICE

Iodine povacrylex in isopropyl alcohol [Duraprep®, 3M]

At the operating room arrival a few minutes before the incision, cleansing and skin antisepsis is done with the prefilled device with iodine povacrylex in isopropyl alcohol as recommended by 3M.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

InteguSEAL® (Kimberly Clark) Duraprep® (3M)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients \>= 18 years undergoing elective clean or clean-contaminated breast, gynecologic or digestive tract surgery
* Accepts to participate and signs the informed consent form
* Have a telephone number to be contacted after surgery

Exclusion Criteria

* Previous allergy to one of the study products
* Two or more procedures in different anatomical sites at the same time / surgery (v.g. hysterectomy and mastectomy)
* Pregnancy
* Breast feeding
* Contaminated or infected surgeries
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kimberly-Clark de México

UNKNOWN

Sponsor Role collaborator

National Institute of Cancerología

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Departmentof Infectious Diseases. Instituto Nacional de Cancerología

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Diana Vilar-Compte, MD;MsC

Role: PRINCIPAL_INVESTIGATOR

Instituto Nacional de Cancerologia, Columbia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Institute of Cancerology

Mexico City, Mexico City, Mexico

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Mexico

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Diana Vilar-Compte, MD, MsC

Role: CONTACT

+52 555 628 0400 ext. 262

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Diana Vilar-Compte, MD, MsC

Role: primary

+52 555 628 0400 ext. 262

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

09003INI

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Preoperative Silicone Ointment and Wound Healing
NCT05461157 ENROLLING_BY_INVITATION NA
Antibiotic-coated Braided Suture Study
NCT07322289 NOT_YET_RECRUITING NA